NASDAQ: IKTInhibikase Therapeutics Inc Stock Ownership - Who owns Inhibikase Therapeutics?
Insider buying vs selling
Have Inhibikase Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Roberto Bellini | Director | 2024-10-21 | 1,460,000 | $1.37 | $2.00MBuy |
| Arvind Kush | Director | 2024-10-21 | 145,000 | $1.37 | $198.65kBuy |
| Amit Munshi | Director | 2024-10-21 | 365,000 | $1.37 | $500.05kBuy |
IKT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IKT insiders and whales buy or sell their stock.
IKT Shareholders
What type of owners hold Inhibikase Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sands Capital Life Sciences Pulse Fund II LP | 14.73% | 10,950,000 | $20.81M | Insider |
| Sands Capital Ventures LLC | 14.73% | 10,950,000 | $20.81M | Institution |
| Soleus Capital Management LP | 8.51% | 6,325,000 | $12.02M | Institution |
| Fairmount Funds Management LLC | 8.24% | 6,125,000 | $11.64M | Institution |
| Commodore Capital LP | 7.97% | 5,925,000 | $11.26M | Institution |
| Perceptive Advisors LLC | 7.97% | 5,925,000 | $11.26M | Institution |
| Milton H. Werner | 7.21% | 5,359,022 | $10.18M | Insider |
| Adar1 Capital Management LLC | 6.86% | 5,103,005 | $9.70M | Institution |
| Vanguard Group Inc | 3.82% | 2,838,645 | $5.39M | Institution |
| Nantahala Capital Management LLC | 2.95% | 2,190,000 | $4.16M | Institution |
IKT vs Biotech Stocks
Inhibikase Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.